Recruitment of primitive peripheral blood cells: Synergism of interleukin 12 with interleukin 6 and stromal cell-derived factor-1

Cytokine

Volumn 12, Issue 1, 2000, Pages 1-7

  Grafte Faure, Stéphanie ^a,b   Leveque, Catherine ^a,b   Ketata, Elhem ^a,b   Jean, Paulette ^a,b   Vasse, Marc ^a,b   Soria, Claudine ^a,b   Vannier, Jean Pierre ^a,b  

^a Res Dept Microenvironment Cell I   (France)

^b IFR Physchem Biol Intgd Syst (C   (France)

Author keywords

5 FU; Haematopoietic stem cell; Human; IL 12; IL 6; Peripheral blood; SCF; SDF 1

Indexed keywords

CHEMOKINE; CYTOKINE RECEPTOR; FLUOROURACIL; INTERLEUKIN 12; INTERLEUKIN 6; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ARTICLE; CELL DAMAGE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STEM CELL;

EID: 0033988161     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0520     Document Type: Article

References (42)

1. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood. 81:1993;2844-2853.
2. Trevisan M., Yan X.Q., Iscove N.N. Cycle initiation and colony formation in culture by murine marrow cells with long-term reconstituting potential in vivo. Blood. 88:1996;4149-4158.
3. 0and entry into the cell cycle of primitive human hematopoietic progenitors. Proc Natl Acad Sci U S A. 89:1992;4013-4017.
4. Lemischka I.R., Raulet D.H., Mulligan R.C. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell. 45:1986;917-927.
5. Matthews W., Jordan C.T., Wiegand G.W., Pardoll D., Lemischka I.R. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell. 65:1991;1143-1152.
6. Metcalf D. Hematopoietic regulators: redundancy or subtlety? Blood. 82:1993;3515-3523.
7. Baggiolini M. Chemokines and leukocytes traffic. Nature. 392:1998;565-568.
8. Murphy P.M. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Fact Rev. 7:1996;47-64.
9. Nagasawa T., Kikutani H., Kishimoto T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci U S A. 91:1994;2305-2309.
10. Tashiro K., Tada H., Heilker R., Shirozu M., Nakano T., Honjo T. Signal sequence trap: a cloning strategy for secreted proteins and type 1 membrane proteins. Science. 261:1993;600-603.
11. Bleul C.C., Fuhlbrigge R.C., Casasnovas J.M., Aiuti A., Springer T.A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 184:1996;1101-1109.
12. Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J.L., Arenzana-Seisdedos F., Schwartz O., Heard J.M., Clark-Lewis I., Legler D.F., Loetscher M., Baggiolini M., Moser B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 382:1996;833-835.
13. Bleul C.C., Fazzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T.A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 382:1996;829-833.
14. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y., Yoshida N., Kikutani H., Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 382:1996;635-638.
15. +progenitors to peripheral blood. J Exp Med. 185:1997;111-120.
16. Kim C.H., Broxmeyer H.E. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood. 91:1998;100-110.
17. Katayama N., Clark S.C., Ogawa M. Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors. Blood. 81:1993;610-616.
18. Mahmud N., Katayama N., Ohishi K., Itoh R., Minami N., Shiku H. Stage-specific cell-cycling of hematopoietic progenitor cells. Leukemia. 11:1997;461-463.
19. Rich I.N. The effect of 5-FU on erythropoiesis. Blood. 77:1991;1164-1170.
20. Rice A., Barbot C., Lacombe F., Dubosc-Marchenay N., Marit G., Hau F., Boiron J.M., Reiffers J. 5-fluorouracil permits access to a primitive subpopulation of peripheral blood stem cells. Stem Cells. 11:1993;326-335.
21. Rice A., Boiron J.M., Barbot C., Dupouy M., Dubosc-Marchenay N., Dumain P., Lacombe F., Reiffers J. Cytokine-mediated expansion of 5-FU-resistant peripheral blood stem cells. Exp Hematol. 23:1995;303-308.
22. Hodgson G.S., Bradley T.R. Properties of haematopoietic stem cells surviving 5-Fluorouracil treatment: evidence for a pre-CFU-S cell? Nature. 281:1979;381-382.
23. Lerner C., Harrison D.E. 5-fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp Hematol. 18:1990;114-118.
24. 1phase of the cell cycle. Blood. 90:1997;4384-4393.
25. Randall T.D., Weissman I.L. Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood. 89:1997;3596-3606.
26. Suda T., Suda J., Ogawa M. Permissive role of interleukin-3 (IL3) in proliferation and differentiation of multipotential hemopoietic progenitors in culture. J Cell Physiol. 124:1985;182-190.
27. Haylock D.N., Horsfall M.J., Dowse T.L., Ramshaw H.S., Niutta S., Protopsaltis S., Peng L., Burrell C., Rappold I., Buhring H.J., Simmons P.J. Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand. Blood. 90:1997;2260-2272.
28. Reddy G., Tiarks C.Y., Pang L., Wuu J., Hsieh C., Quesenberry P.J. Cell cycle analysis and synchronization of pluripotent hematopoietic progenitor stem cells. Blood. 90:1997;2293-2299.
29. Ikebuchi K., Ihle J.N., Hirai Y., Wong G.G., Clark S.C., Ogawa M. Synergistic factors for stem cell proliferation: further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor. Blood. 72:1988;2007-2014.
30. Ogawa M. Hemopoietic stem cells: stochastic differentiation and humoral control of proliferation. Environ Health Perspect. 80:1978;199-207.
31. Metcalf D. The cellular basis for enhancement interactions between SCF and the colony stimulating factors. Stem Cells. 11:1993;1-11.
32. Tanaka R., Katayama N., Ohishi K., Mahmud N., Itoh R., Tanaka Y., Komada Y., Minami N., Sakurai M., Shirakawa S., Shiku S. Accelerated cell-cycling of hematopoietic progenitor cells by growth factors. Blood. 86:1995;73-79.
33. Hirayama F., Katayama N., Neben S., Donaldson D., Nickbarg E.B., Clark S.C., Ogawa M. Synergistic interaction between interleukin-12 and steel factor in support of proliferation of murine lymphohematopoietic progenitors in culture. Blood. 83:1994;92-98.
34. Hirao A., Takaue Y., Kawano Y., Sato J., Suzue T., Abe T., Saito S.I., Kawahito M., Okamoto Y., Makimoto A., Kuroda Y. Synergism of interleukin 12, interleukin 3 and serum factor on primitive human hematopoietic progenitor cells. Stem Cells. 13:1995;47-53.
35. +cells. Am J Hematol. 58:1998;183-188.
36. Springer T.A. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol. 57:1995;827-872.
37. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC-chemokines. Adv Immunol. 55:1994;97-179.
38. Carr M.W., Roth S., Luther E., Rose S.S., Springer T.A. Monocyte chemoattractant protein-1 is a major T lymphocyte chemoattractant. Proc Natl Acad Sci U S A. 91:1994;3652-3656.
39. Jiang W., Zhou P., Kahn S.M., Tomita N., Johnson M.D., Weinstein I.B. Molecular cloning of TPAR-1, a gene whose expression is repressed by the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA). Exp Cell Res. 215:1994;284-293.
40. +hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood. 91:1998;4523-4530.
41. Broxmeyer H.E., Sherry B., Cooper S., Lu L., Maze R., Beckmann M.P., Cerami A., Ralph P. Comparative analysis of human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells - interacting effects involving suppression, synergistic suppression, and blocking suppression. J Immunol. 150:1993;3448-3458.
42. Broxmeyer H.E., Cooper S., Hague N., Benninger L., Sarris A., Cornetta K., Vadhan-Raj S., Hendrie P., Mantel C. Human chemokine: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice. Ann Hematol. 71:1995;235-246.